Kidney and Transplant Specialists
UpdateOPTN Region 3 member (interim)
MissionProvide innovative diagnostic and therapeutic options to patients throughout their transplant journey.
Read More (opens in a new tab)
Research
Ferumoxytol is FDA-approved for the treatment of iron deficiency anemia. The compound also has superparamagnetic properties that have utility in clinical magnetic resonance imaging. Our studies have demonstrated the utility of ferumoxytol as an alternative to gadolinium in patients with kidney disease before and after transplant.
Vascular progenitor cells show promise for the treatment of microvascular injury in kidney disease however limitations of application have been due to non-targeted patient populations. We investigate the function of endothelial progenitor cells (EPC) derived from the blood vessels of a patient's kidney which can be used for tailored treatment before and after kidney transplant.